Biocatalytic cascade process of islatravir: Analytical and regulatory control strategy of minor enantiomer.

[1]  Christopher C. Nawrat,et al.  Synthesis of Islatravir Enabled by a Catalytic, Enantioselective Alkynylation of a Ketone. , 2020, Organic letters.

[2]  Christopher C. Nawrat,et al.  Nine-Step Stereoselective Synthesis of Islatravir from Deoxyribose. , 2020, Organic letters.

[3]  Shane T. Grosser,et al.  Design of an in vitro biocatalytic cascade for the manufacture of islatravir , 2019, Science.

[4]  Lorna J. Hepworth,et al.  Biocatalysis , 2018, Nature Reviews Methods Primers.

[5]  Marian E. Gindy,et al.  Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention , 2018, Antimicrobial Agents and Chemotherapy.

[6]  Huimin Zhao,et al.  Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates. , 2017, Bioorganic & medicinal chemistry.

[7]  Matthew D Truppo,et al.  Biocatalysis in the Pharmaceutical Industry: The Need for Speed. , 2017, ACS medicinal chemistry letters.

[8]  D. Murray,et al.  Enantioselective Synthesis of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) via Enzymatic Desymmetrization. , 2017, Organic letters.

[9]  K. Fukuyama,et al.  Synthesis of EFdA via a diastereoselective aldol reaction of a protected 3-keto furanose. , 2015, Organic letters.

[10]  Andrew D. Huber,et al.  4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms* , 2014, The Journal of Biological Chemistry.

[11]  S. Kuwahara,et al.  Concise Synthesis of the Anti-HIV Nucleoside EFdA , 2012, Bioscience, biotechnology, and biochemistry.

[12]  S. Kuwahara,et al.  Enantioselective total synthesis of the potent anti-HIV nucleoside EFdA. , 2011, Organic letters.

[13]  M. D. del Nozal,et al.  Study of the enantiomeric separation of an acetamide intermediate by using supercritical fluid chromatography and several polysaccharide based chiral stationary phases. , 2011, Journal of chromatography. A.

[14]  T. Ikai,et al.  Structure control of polysaccharide derivatives for efficient separation of enantiomers by chromatography. , 2009, Chemical reviews.

[15]  Junhua Tao,et al.  Biocatalysis in development of green pharmaceutical processes. , 2009, Current opinion in chemical biology.

[16]  B. Koppenhoefer,et al.  Enantiomeric Separation of Several Oxirane Derivatives by High Performance Liquid Chromatography on Polysaccharide-Based Chiral Stationary Phases , 2008 .

[17]  John M Woodley,et al.  New opportunities for biocatalysis: making pharmaceutical processes greener. , 2008, Trends in biotechnology.

[18]  Zhe Xu,et al.  Enantioseparation of 2-aryl-1,3-dicarbonyl analogues by high performance liquid chromatography using polysaccharide type chiral stationary phase. , 2008, Chirality.

[19]  M. Matsuoka,et al.  2′-Deoxy-4′-C-Ethynyl-2-Fluoroadenosine: A Nucleoside Reverse Transcriptase Inhibitor with Highly Potent Activity Against Wide Spectrum of HIV-1 Strains, Favorable Toxic Profiles, and Stability in Plasma , 2007, Nucleosides, nucleotides & nucleic acids.

[20]  John M Woodley,et al.  Biocatalysis for pharmaceutical intermediates: the future is now. , 2007, Trends in biotechnology.